Benralizumab (MEDI-563) is a cytolytic monoclonal antibody that targets the interleukin-5 receptor ?? (IL-5R??), facilitating direct, rapid, and near-complete depletion of eosinophils through enhanced antibody-dependent cell-mediated cytotoxicity (ADCC). This agent is specifically designed for the treatment of severe eosinophilic asthma, offering a targeted therapeutic approach by modulating the eosinophilic inflammatory response that characterizes this condition.
Benralizumab (MEDI-563) is a cytolytic monoclonal antibody that targets the interleukin-5 receptor ?? (IL-5R??), facilitating direct, rapid, and near-complete depletion of eosinophils through enhanced antibody-dependent cell-mediated cytotoxicity (ADCC). This agent is specifically designed for the treatment of severe eosinophilic asthma, offering a targeted therapeutic approach by modulating the eosinophilic inflammatory response that characterizes this condition.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
